GeoVax Labs, Inc. has entered into a Sales Agreement with A.G.P./Alliance Global Partners to potentially sell up to $4,486,846 worth of common stock, with A.G.P. receiving a 3% commission on sales. The agreement allows for sales to occur at market prices based on the company's instructions, but there is no obligation to sell any shares.